Abstract
ABSTRACT Regulated markets such as Japan face challenges in balancing the value of pharmaceutical drugs and market dynamics, resulting in inappropriate business practices. This paper describes a currently important trading issue in Japan, namely pending price settlements and provisional deliveries. This practice is a unique Japanese business custom, which leads inefficiency. The paper examines factors attributed to this practice and its consequences.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
